Brief: TheraVet Says Is The Subject Of Graftys' Unfounded Requests On VISCO-VET IP

Theravet SA

07/10/2021 16:58

Oct 7 (Reuters) - Theravet SA  ALVET.PA :
    * PROVIDES DETAILS ON ITS RELATIONS WITH THE COMPANY GRAFTYS
    * THERAVET IS THE SUBJECT, BY THE COMPANY GRAFTYS, OF
REQUESTS
WITHOUT FOUNDATION OR RELEVANT DOCUMENTS CONCERNING THE
INTELLECTUAL PROPERTY OF THE VISCO-VET TECHNOLOGY
    * GENERAL MANAGEMENT AND BOARD OF DIRECTORS ARE ASTONISHED
AT SUCH
ACTIONS FROM GRAFTYS, WHICH CLAIMS JOINT OWNERSHIP OF THE
PATENTS AND KNOW-HOW ON THE VISCO-VET TECHNOLOGY EVEN THOUGH
THIS TECHNOLOGY HAS BEEN ACQUIRED UNDER LICENSED BY THERAVET IN
2017
    * THIS VISCO-VET TECHNOLOGY IS ALSO COMPLETELY DIFFERENT
FROM THE
"GRAFTYS" TECHNOLOGY, AS CONFIRMED BY THE INTELLECTUAL PROPERTY
ATTORNEYS OF THERAVET
    * CONFIRMS THAT IN ORDER TO ENSURE THE TECHNOLOGY COMMERCIAL
DEPLOYMENT, IT HAS BUILT UP ENOUGH STOCKS TO COVER THE MOST
AGGRESSIVE SALES PROJECTIONS IN THE TARGET TERRITORIES, EVEN IF
THE CONTRACT FOR THE SUPPLY OF CERTAIN RAW MATERIALS WOULD BE
TERMINATED AS CLAIMED BY GRAFTYS

Source text for Eikon:  ID:nBwldLysa 
Further company coverage:  ALVET.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))